United Services Automobile Association Cuts Stake in Danaher Co. (NYSE:DHR)

United Services Automobile Association trimmed its holdings in Danaher Co. (NYSE:DHR) by 4.9% in the second quarter, according to the company in its most recent filing with the SEC. The fund owned 18,734 shares of the conglomerate’s stock after selling 969 shares during the quarter. United Services Automobile Association’s holdings in Danaher were worth $4,681,000 at the end of the most recent quarter.

A number of other institutional investors also recently made changes to their positions in the business. Cape Investment Advisory Inc. purchased a new position in shares of Danaher in the fourth quarter worth $25,000. Tsfg LLC grew its holdings in Danaher by 733.3% in the 1st quarter. Tsfg LLC now owns 100 shares of the conglomerate’s stock worth $25,000 after acquiring an additional 88 shares during the last quarter. CarsonAllaria Wealth Management Ltd. bought a new position in shares of Danaher during the second quarter valued at about $25,000. nVerses Capital LLC purchased a new stake in shares of Danaher during the second quarter worth about $25,000. Finally, Redmont Wealth Advisors LLC purchased a new stake in shares of Danaher during the first quarter worth about $30,000. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Danaher Stock Up 0.6 %

DHR stock opened at $266.20 on Monday. The stock has a market capitalization of $192.25 billion, a P/E ratio of 45.12, a P/E/G ratio of 4.38 and a beta of 0.83. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.43 and a quick ratio of 1.04. Danaher Co. has a 1-year low of $182.09 and a 1-year high of $281.70. The business has a fifty day moving average price of $261.30 and a 200-day moving average price of $255.82.

Danaher (NYSE:DHR) last released its quarterly earnings data on Tuesday, July 23rd. The conglomerate reported $1.72 EPS for the quarter, topping the consensus estimate of $1.57 by $0.15. The company had revenue of $5.74 billion during the quarter, compared to the consensus estimate of $5.59 billion. Danaher had a return on equity of 11.06% and a net margin of 16.94%. Danaher’s revenue for the quarter was down 2.9% on a year-over-year basis. During the same period last year, the company earned $2.05 EPS. Equities analysts forecast that Danaher Co. will post 7.59 earnings per share for the current fiscal year.

Insider Activity

In related news, SVP Brian W. Ellis sold 9,600 shares of the firm’s stock in a transaction that occurred on Thursday, July 25th. The shares were sold at an average price of $275.16, for a total value of $2,641,536.00. Following the sale, the senior vice president now owns 20,230 shares in the company, valued at $5,566,486.80. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. In other news, SVP Brian W. Ellis sold 9,600 shares of the stock in a transaction on Thursday, July 25th. The stock was sold at an average price of $275.16, for a total transaction of $2,641,536.00. Following the transaction, the senior vice president now directly owns 20,230 shares of the company’s stock, valued at approximately $5,566,486.80. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, SVP Georgeann Couchara sold 952 shares of the firm’s stock in a transaction on Monday, August 26th. The stock was sold at an average price of $268.37, for a total value of $255,488.24. Following the completion of the transaction, the senior vice president now owns 4,212 shares in the company, valued at $1,130,374.44. The disclosure for this sale can be found here. Insiders sold 39,659 shares of company stock valued at $11,042,433 over the last three months. Insiders own 11.10% of the company’s stock.

Analyst Ratings Changes

A number of research analysts have commented on DHR shares. Royal Bank of Canada reaffirmed an “outperform” rating and set a $300.00 price target on shares of Danaher in a research report on Friday. StockNews.com lowered Danaher from a “buy” rating to a “hold” rating in a research note on Tuesday, June 25th. TD Cowen boosted their price objective on shares of Danaher from $290.00 to $310.00 and gave the company a “buy” rating in a research report on Wednesday, July 24th. Barclays upped their price objective on shares of Danaher from $270.00 to $285.00 and gave the stock an “equal weight” rating in a report on Wednesday, July 24th. Finally, Wells Fargo & Company assumed coverage on shares of Danaher in a research report on Tuesday, August 27th. They set an “equal weight” rating and a $280.00 price target on the stock. Seven investment analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the stock. Based on data from MarketBeat.com, Danaher currently has a consensus rating of “Moderate Buy” and a consensus target price of $278.94.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.